| abstract |
the present invention, in one aspect, provides a method of treating cancer in a human in need thereof, the method comprising administering to the human a therapeutically effective amount of a protein inhibitor arginine methyltransferase type ii (prmt type ii) and administering to the a therapeutically effective amount of a single-binding protein or antigen-binding portion thereof. in another aspect, the present invention provides an arginine methyltransferase type ii protein inhibitor (prmt type ii) and a single-binding protein or antigen-binding fragment thereof for use in the treatment of cancer in a human in need thereof. |